Clinical Trial

Clinical Evaluation of Nano-Hydroxyapatite as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intra-bony Defects

Study acronym: MINST
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled clinical trial aims to evaluate the effectiveness of using nano-hydroxyapatite (nHA) gel alongside a minimally invasive non-surgical technique (MINST) to treat deep intra-bony defects in patients with Stage III periodontitis. While MINST is an effective method for cleaning deep periodontal pockets without the need for traditional surgery, the addition of nHA may further enhance soft tissue healing, improve cellular interaction, and promote bone regeneration. Participants in the study will be randomly assigned to one of two groups. The test group will receive the MINST procedure combined with the application of nHA gel directly into the periodontal pocket, while the control group will receive the MINST procedure alone. The primary goal of the study is to measure the decrease in probing pocket depth over a 6-month follow-up period to determine if the adjunctive use of nHA provides superior clinical outcomes compared to non-surgical treatment alone.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-20.
Trial Details
NCT Number NCT07608783
Lead Sponsor Cairo University
Conditions Periodontitis, Intrabony Periodontal Defect
Enrollment 28 participants
Start Date 2025-07-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-28 (estimated)
Updated on ClinicalTrials.gov 2026-05-29